204 results on '"Maciaczyk, J"'
Search Results
2. POS0111 PILOT STUDY ON EVOKED COMPOUND ACTION POTENTIAL CONTROLLED CLOSED-LOOP SPINAL CORD STIMULATION IN TREATMENT OF RAYNAUD’S PHENOMENON
3. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
4. Pilotstudie zur Untersuchung von evozierten Summenaktionspotentialen (evoked compound action potentials) ECAP-gesteuerter Rückenmarkstimulation (SCS) bei primärem und sekundärem Raynaud-Phänomen
5. Delayed functional maturation of human neuronal progenitor cells in vitro
6. HIGHLY SIGNIFICANT PAIN REDUCTION WITH ADVANCED NEURAL TARGETING SCS IN PREDOMINANT BACK PAIN PATIENTS: WIP16–0395
7. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation
8. An in vitro technology to score therapeutic efficacy and risk-potential of substances for targeting brain tumours
9. Magnetic resonance imaging-guided focused ultrasound thalamotomy in spinocerebellar ataxia 12 associated tremor - a case report
10. Vario-guided biopsy vs. stereotactic frame biopsy - a single-centre experience
11. Neural cell transplantation in patients with neurodegenerative disorders: in vitro validation and safety assessment: OP-088
12. 011: Transplantation of fetal striatal cells in patients with Huntingtonʼs disease: the German experience within a European-based multi-center study
13. A novel receptor-specific anti-Notch therapy to block glioma cell invasion
14. Successful pain relief using Multiple Independent Current Control technology (MICC) and 3D-IlluminaTM programming platform following failure of the conventional SCS systems
15. Pharmacological WNT inhibition acts synergistically with chemo- and radiotherapy in glioblastoma through aldehyde dehydrogenase 3A1
16. Burst or tonic stimulation? Results from a prospective placebo controlled, double blinded, study – 2y follow up
17. Technical aspects and outcome in Sphenopalatine ganglion stimulation (SPG) for Cluster headache
18. WNT/beta-catenin signaling regulates aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to induce temozolomide resistance in glioblastoma cells
19. DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets
20. Successful combination of SPG and ONS for cluster headache
21. Pharmacological WNT-inhibition acts synergistically with chemo- and radiotherapy by overcoming treatment-resistance in glioma stem cells
22. Cervical and high-thoracic dorsal root ganglion stimulation (DRG) in chronic pain
23. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
24. PILOT STUDY ON EVOKED COMPOUND ACTION POTENTIAL CONTROLLED CLOSED-LOOP SPINAL CORD STIMULATION IN TREATMENT OF RAYNAUD'S PHENOMENON.
25. Succesful combination of ONS and SPG
26. Targeting brain tumor stem cells by interfering with choline metabolism: Evidence for an EMT-choline oncometabolic network
27. Long-term surgical complications of Deep Brain Stimulation in Parkinson's disease patients - single center experience
28. Occipital Nerve stimulation (ONS) with body compliant leads for treatment of chronic migraine
29. Novel inhibitor of the canonical WNT-pathway LGK974 impedes the in vitro growth of glioblastoma cell lines decreasing the tumor stem cell compartment
30. Hybrid stimulation treatment of dominant back pain patients with Precision Spectra™ system – German experience
31. Occipital Nerve Stimulation (ONS) with body compliant leads for chronic migraine treatment
32. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways
33. Infection rates of percutaneously implanted leads for spinal cord stimulation after a trial phase: 4-year follow-up
34. Predictability of dorsal root ganglion stimulation via prior transforaminal epidural injections for the treatment of peripheral neuropathies
35. Occipital nerve stimulation for primary chronic headache disorders – A randomized trial on treatment efficacy
36. Dorsal root ganglion stimulation for treatment of phantom limb pain
37. Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to the increase of CD133+ cell population in human glioblastoma-derived cultures in lowered oxygen tension
38. The role of canonical WNT/beta-catenin signaling in glial brain tumors
39. Neural transplantation in patients with Huntington's disease: preliminary risk and outcome assessment
40. Neuromodulative treatment of dominant back pain with percutaneous implanted 2x16 contact leads (Infinion(TM)) and Precision Spectra(TM) SCS system - Technique and one-year follow up
41. Predictability of dorsal root ganglion stimulation via prior PRI injection and RF stimulation for the treatment of peripheral neuropathies
42. Managing intractable post-herpetic neuralgia (PHN) using spinal cord stimulation (SCS): A case report
43. Dorsal root ganglion stimulation for treatment of phantom limb pain
44. Complication rates of percutaneously implanted leads for Scs after a trial phase: 5-year follow-up
45. Safety and toxicity of fetal whole ganglionic eminence progenitor cell transplantation in Huntington's Disease patients
46. The influence of in vitro conditions for the enrichment of stem-like cell population in primary human brain tumor cultures
47. Transplantation von langzeit-expandierten humanen fötalen neuronalen Vorläuferzellen: Indiz für ferne Migration und Differenzierung zu unterschiedlichen Zellpopulationen
48. Elektrophysiologische Eigenschaften von humanen neuronalen progenitoren Zellen während Differenzierung
49. Epigenetische Induktion von Phänotyp-spezifischer Differenzierung expandierter humaner fötalen neuronalen Vorläuferzellen
50. Training fördert Überleben und funktionelle Integration dopaminerger, nigraler Transplantate nach Läsion mit 6-OHDA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.